Prudential Financial’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-83,973
| Closed | -$10.8M | – | 2431 |
|
|
2025
Q2 | $10.8M | Sell |
83,973
-9,495
| -10% | -$986K | 0.01% | 616 |
|
|
2025
Q1 | $8.27M | Sell |
93,468
-7,070
| -7% | -$690K | 0.01% | 666 |
|
|
2024
Q4 | $8.77M | Buy |
100,538
+10,687
| +12% | +$979K | 0.01% | 663 |
|
|
2024
Q3 | $8.31M | Buy |
89,851
+15,301
| +21% | +$1.52M | 0.01% | 757 |
|
|
2024
Q2 | $8.03M | Sell |
74,550
-29,614
| -28% | -$2.96M | 0.01% | 739 |
|
|
2024
Q1 | $9.88M | Buy |
104,164
+42,041
| +68% | +$3.61M | 0.01% | 692 |
|
|
2023
Q4 | $5.73M | Sell |
62,123
-13,213
| -18% | -$856K | 0.01% | 868 |
|
|
2023
Q3 | $3.78M | Sell |
75,336
-47,887
| -39% | -$2.56M | 0.01% | 1015 |
|
|
2023
Q2 | $7.79M | Buy |
123,223
+118,248
| +2,377% | +$6.43M | 0.01% | 738 |
|
|
2023
Q1 | $224K | Sell |
4,975
-28
| -0.6% | -$1.26K | ﹤0.01% | 2363 |
|
|
2022
Q4 | $219K | Sell |
5,003
-2
| -0% | -$96 | ﹤0.01% | 2373 |
|
|
2022
Q3 | $329K | Sell |
5,005
-1,479
| -23% | -$95K | ﹤0.01% | 2266 |
|
|
2022
Q2 | $339K | Sell |
6,484
-57,054
| -90% | -$3.34M | ﹤0.01% | 2293 |
|
|
2022
Q1 | $4.06M | Sell |
63,538
-47,126
| -43% | -$3.38M | 0.01% | 1083 |
|
|
2021
Q4 | $11.9M | Buy |
110,664
+2,706
| +3% | +$283K | 0.01% | 676 |
|
|
2021
Q3 | $11.1M | Sell |
107,958
-26,801
| -20% | -$2.5M | 0.02% | 698 |
|
|
2021
Q2 | $11.9M | Sell |
134,759
-56,747
| -30% | -$5.2M | 0.02% | 702 |
|
|
2021
Q1 | $18.6M | Buy |
191,506
+41,948
| +28% | +$4.19M | 0.03% | 521 |
|
|
2020
Q4 | $16.8M | Buy |
149,558
+144,171
| +2,676% | +$15.2M | 0.03% | 517 |
|
|
2020
Q3 | $500K | Buy |
5,387
+746
| +16% | +$57.4K | ﹤0.01% | 1961 |
|
|
2020
Q2 | $362K | Buy |
4,641
+213
| +5% | +$14.4K | ﹤0.01% | 2042 |
|
|
2020
Q1 | $259K | Sell |
4,428
-90
| -2% | -$5.79K | ﹤0.01% | 2108 |
|
|
2019
Q4 | $362K | Buy |
4,518
+39
| +0.9% | +$2.92K | ﹤0.01% | 2150 |
|
|
2019
Q3 | $329K | Sell |
4,479
-14,617
| -77% | -$1.26M | ﹤0.01% | 2172 |
|
|
2019
Q2 | $1.8M | Buy |
19,096
+10,421
| +120% | +$860K | ﹤0.01% | 1644 |
|
|
2019
Q1 | $694K | Buy |
8,675
+4,358
| +101% | +$322K | ﹤0.01% | 1994 |
|
|
2018
Q4 | $232K | Sell |
4,317
-24
| -0.6% | -$1.46K | ﹤0.01% | 2201 |
|
|
2018
Q3 | $339K | Sell |
4,341
-190
| -4% | -$13.2K | ﹤0.01% | 2150 |
|
|
2018
Q2 | $288K | Sell |
4,531
-196
| -4% | -$15.6K | ﹤0.01% | 2218 |
|
|
2018
Q1 | $433K | Buy |
4,727
+153
| +3% | +$13.2K | ﹤0.01% | 2046 |
|
|
2017
Q4 | $345K | Sell |
4,574
-420
| -8% | -$29.6K | ﹤0.01% | 2109 |
|
|
2017
Q3 | $348K | Sell |
4,994
-69,410
| -93% | -$3.71M | ﹤0.01% | 2108 |
|
|
2017
Q2 | $3.77M | Buy |
74,404
+57,100
| +330% | +$2.42M | 0.01% | 1259 |
|
|
2017
Q1 | $692K | Buy |
17,304
+984
| +6% | +$35.2K | ﹤0.01% | 1959 |
|
|
2016
Q4 | $458K | Buy |
+16,320
| New | +$492K | ﹤0.01% | 2052 |
|
Other funds holding BPMC
IA
HNB
Prudential Financial's BPMC Position: Q3 2025 in Review
Prudential Financial sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 83,973 shares — an estimated $10.8M sold.
Prudential Financial first reported a position in BPMC in Q4 2016 and held it in 35 quarters. The position peaked at $18.6M in Q1 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Prudential Financial reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Prudential Financial sold 83,973 Blueprint Medicines shares in Q3 2025, an estimated $10.8M.
- Prudential Financial first reported a position in Blueprint Medicines in Q4 2016 and held it in 35 quarters.
- Prudential Financial's Blueprint Medicines position peaked at $18.6M in Q1 2021.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Prudential Financial's 13F filing for Q3 2025, filed 13 Nov 2025.